Concurrent Chemoradiation with Low-Dose Weekly Cisplatin in Locally Advanced Stage IV Head and Neck Squamous Cell Carcinoma

PURPOSE: Concurrent chemoradiation (CRT) with 3-weekly doses of cisplatin is a standard treatment for loco-regionally advanced head and neck squamous cell carcinoma (HNSCC). However, treatment with 3-weekly doses of cisplatin is often associated with several adverse events. Therefore, we conducted t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Myoung Hee, Kang, Jung Hun, Song, Haa-Na, Jeong, Bae Kwon, Chai, Gyu Young, Kang, Kimun, Woo, Seung Hoon, Park, Jung Je, Kim, Jin Pyeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506097/
https://www.ncbi.nlm.nih.gov/pubmed/25672576
http://dx.doi.org/10.4143/crt.2013.219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506097/
https://www.ncbi.nlm.nih.gov/pubmed/25672576
http://dx.doi.org/10.4143/crt.2013.219

Ejemplares similares